Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
112年第3季財務報告書 — 202301_1734_AI1.pdf
Regulatory Filings
2023-11-14 Chinese
112年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a company over specific periods (the first three quarters of the year 112 and 111 in the Taiwanese calendar). The data includes items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and other equity components. The presence of detailed financial data and accounting items related to equity changes indicates this is a financial report rather than a brief announcement or certification. The document length is 3953 characters, which is relatively short but contains substantive financial data. The content corresponds to a comprehensive financial report for a period shorter than a full fiscal year (three quarters), which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, nor is it a full annual report or audit report. Therefore, the best classification is Interim / Quarterly Report (IR).
2023-11-13 Chinese
112年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the third quarter of the fiscal year 112 (which corresponds to 2023 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2416 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-11-13 Chinese
112年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed consolidated income statement data for the third quarter of the fiscal year 112 (2023) and comparative periods, including quarterly and year-to-date financial figures. It includes comprehensive financial metrics such as revenue, costs, expenses, net income, and earnings per share. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3655 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-11-13 Chinese
112年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 112年09月30日 (September 30, 2023) and 111年12月31日 (December 31, 2022). It includes comprehensive financial statement items such as assets, liabilities, equity, and detailed breakdowns. The document length is 3877 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of actual financial figures and accounting items indicates this is a financial report for a period shorter than a full fiscal year (quarterly data). The document is not a mere announcement or certification, nor is it a summary or presentation. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-11-13 Chinese
112年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (杏輝) providing information about guarantees and endorsements, including amounts and limits, for the current and previous months. It contains specific financial data but is very short (624 characters) and focuses on guarantee and endorsement balances rather than comprehensive financial statements or management discussion. There is no indication of it being an annual or interim report, audit report, or earnings release. It is a regulatory disclosure related to financial guarantees, which typically falls under general regulatory announcements. Given the short length and nature of the content, it does not qualify as a full financial report but rather a regulatory filing disclosure.
2023-11-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.